Auteur M. SCHWARTZ

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Craving and control : Methamphetamine users' narratives

BRUEHL A.M. ; D. H. LENDE ; M. SCHWARTZ ; C. E. STERK ; ELIFSON K. | 2006
Dans Journal of Psychoactive Drugs (Vol.38, Suppl.3, 2006) Article : Périodique

ENGLISH : In this article the authors explore the experience of craving of methamphetamine users and seek to illuminate how differences in craving contribute to use patterns. Using in-depth interviewing, data were collected from 82 active meth[...]

Plus d'info

Ajouter à la sélection

A placebo-controlled screening trial of celecoxib for the treatment of cocaine dependence

M. S. REID ; B. ANGRIST ; S. BAKER ; WOO C. ; M. SCHWARTZ ; A. MONTGOMERY ; M. D. MAJEWSKA ; J. ROBINSON ; J. ROTROSEN | 2005
Périodique

ENGLISH : Aims : To conduct a medication screening trial study on the efficacy of celecoxib versus placebo for the treatment of cocaine dependence. Design : A modified blinded, parallel group study in an outpatient setting using the Cocaine Ra[...]

Plus d'info

Ajouter à la sélection

"Zombie" outbreak caused by the synthetic cannabinoid AMB-FUBINACA in New York

A. J. ADAMS ; S. D. BANISTER ; L. IRIZARRY ; J. TRECKI ; M. SCHWARTZ ; R. GERONA | 2017
Dans New England Journal of Medicine (Vol.376, n°3, January 19, 2017) Article : Périodique

Background: New psychoactive substances constitute a growing and dynamic class of abused drugs in the United States. On July 12, 2016, a synthetic cannabinoid caused mass intoxication of 33 persons in one New York City neighborhood, in an event [...]

Plus d'info

Ajouter à la sélection